Belgium (BE)

Examining the effectiveness of a web-based intervention for symptoms of depression and anxiety in college students: Study protocol of a randomised controlled trial (2019) Karyotaki E, Klein AM, Riper H, Wit LD, Krijnen L, Bol E, Bolinski F, et al. Journal article Thermal expansion of colloidal CdSe/CdS core/shell quantum dots (2019) Moses Badlyan N, Biermann A, Aubert T, Hens Z, Maultzsch J Journal article Arthropod communities in fungal fruitbodies are weakly structured by climate and biogeography across European beech forests (2019) Friess N, Müller JC, Aramendi P, Bässler C, Brändle M, Bouget C, Brin A, et al. Journal article Blood pressure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference (2019) Cheung AK, Chang TI, Cushman WC, Furth SL, Ix JH, Pecoits-Filho R, Perkovic V, et al. Journal article Needle-like structures discovered on positively charged lightning branches (2019) Hare BM, Scholten O, Dwyer J, Trinh TN, Buitink S, ter Veen S, Bonardi A, et al. Journal article Sodium chloride triggers Th17 mediated autoimmunity (2019) Haase S, Wilck N, Kleinewietfeld M, Mueller DN, Linker R Journal article, Review article Regional Multi-View Learning for Cardiac Motion Analysis: Application to Identification of Dilated Cardiomyopathy Patients (2019) Puyol-Anton E, Ruijsink B, Gerber B, Amzulescu MS, Langet H, De Craene M, Schnabel JA, et al. Journal article Plasma environment effects on K lines of astrophysical interest: I. Atomic structure, radiative rates, and Auger widths of oxygen ions (2019) Deprince J, Bautista MA, Fritzsche S, Garcia J, Kallman TR, Mendoza C, Palmeri P, Quinet P Journal article EFFECTS OF BASELINE PREDNISONE DOSE ON REMISSION AND DISEASE FLARE IN PATIENTS WITH GIANT CELL ARTERITIS TREATED WITH TOCILIZUMAB IN THE GIACTA TRIAL (2019) Stone JH, Tuckwell K, Dimonaco S, Klearman M, Aringer M, Blockmans D, Brouwer E, et al. Conference contribution Secukinumab provides sustained improvements in the signs and symptoms in psoriatic arthritis: final 5-year efficacy and safety results from the FUTURE 1 Phase 3 trial (2019) Tahir H, Mease PJ, Kavanaugh A, Reimold A, Rech J, Hall S, Geusens P, et al. Conference contribution